|
Indications:
Adolescents (≥12 years)
Saxenda® can be used as an adjunct to a healthy nutrition and increased physical activity for weight management in adolescent patients from the age of 12 years and above with:
• an inadequate response to reduced calorie diet and increased physical activity alone, and
• obesity (BMI corresponding to ≥30 kg/m2 for adults by international cut-off points) and
• body weight above 60 kg.
Limitations of Use: The safety and effectiveness of Saxenda® in pediatric patients with type 2 diabetes have not been established.
Treatment with Saxenda® should be discontinued and re-evaluated if patients have not lost at least 4% of their BMI or BMI z score after 12 weeks on the 3.0 mg/day or maximum tolerated dose.
|